Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	89829
Country	China

Received	2023-11-14 05:37
Peer-Review Started	2023-11-14 05:39
To Make the First Decision
Return for Revision	2024-02-01 08:18
Revised	2024-02-08 05:33
Second Decision	2024-03-14 02:43
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-03-14 04:24
Articles in Press	2024-03-14 04:24
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-04-22 04:49
Publish the Manuscript Online	2024-05-09 13:59

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Case Report
Article Title	Chemoradiotherapy plus tislelizumab for mismatch repair proficient rectal cancer with supraclavicular lymph node metastasis: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Wen-Tao Zhong, Yuan Lv, Qian-Yu Wang, Ran An, Gang Chen and Jun-Feng Du
ORCID	Author(s) ORCID Number Wen-Tao Zhong http://orcid.org/0000-0002-6268-1898 Gang Chen http://orcid.org/0009-0000-1264-1073 Jun-Feng Du http://orcid.org/0000-0002-8482-4271
Funding Agency and Grant Number	Funding Agency Grant Number National Natural Science Foundation of China No. 81870393
Corresponding Author	Jun-Feng Du, MD, Adjunct Professor, Department of General Surgery, The 7th Medical Center of PLA General Hospital, No. 5 NanmenCang, Beijing 100700, China. dujunfeng@301hospital.com.cn
Key Words	Rectal cancer; Metastasis; Chemoradiotherapy; Immunotherapy; Prognosis; Case report
Core Tip	Rectal cancer is a clinically common malignancy and the mainstream treatment methods are chemoradiotherapy (CRT) and surgery. Advanced rectal cancer is often associated with distant organs and lymph node metastasis. We report a case of mismatch repair proficient rectal cancer with left supraclavicular lymph node metastasis. The patient received 4 cycles of CRT combined with immunotherapy and achieved PCR. This case provides a rare clinical experience for such patients.
Publish Date	2024-05-09 13:59
Citation	Zhong WT, Lv Y, Wang QY, An R, Chen G, Du JF. Chemoradiotherapy plus tislelizumab for mismatch repair proficient rectal cancer with supraclavicular lymph node metastasis: A case report. World J Gastrointest Oncol 2024; 16(5): 2219-2224
URL	https://www.wjgnet.com/1948-5204/full/v16/i5/2219.htm
DOI	10.4251/wjgo.v16.i5.2219

Full Article (PDF)	WJGO-16-2219-with-cover.pdf
CARE Checklist–2016	89829-CARE Checklist (2016) .pdf
Manuscript File	89829_Auto_Edited-YJP.docx
Answering Reviewers	89829-Answering reviewers.pdf
Audio Core Tip	89829-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	89829-Conflict-of-interest statement.pdf
Copyright License Agreement	89829-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	89829-Grant application form(s).pdf
Signed Consent for Treatment Form(s) or Document(s)	89829-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	89829-Language certificate.pdf
Peer-review Report	89829-Peer-review(s).pdf
Scientific Misconduct Check	89829-Bing-Qu XL-2.jpg
Scientific Editor Work List	89829-Scientific editor work list.pdf
CrossCheck Report	89829-CrossCheck report.pdf